BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6582321)

  • 1. Specific chromosome translocation in pristane-induced plasmacytomas of NZB mice.
    Oikawa T; Kuzumaki N; Yamada T
    J Natl Cancer Inst; 1984 Feb; 72(2):347-53. PubMed ID: 6582321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromosome translocations and the activation of C-myc oncogene in mouse plasmacytomas].
    Ohno S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):587-96. PubMed ID: 6424577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.
    Ohno S; Migita S; Wiener F; Babonits M; Klein G; Mushinski JF; Potter M
    J Exp Med; 1984 Jun; 159(6):1762-77. PubMed ID: 6202819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.
    Coleman AE; Schröck E; Weaver Z; du Manoir S; Yang F; Ferguson-Smith MA; Ried T; Janz S
    Cancer Res; 1997 Oct; 57(20):4585-92. PubMed ID: 9377573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
    Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
    Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonrandom chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristane-induced mouse plasmacytomas.
    Ohno S; Babonits M; Wiener F; Spira J; Klein G; Potter M
    Cell; 1979 Dec; 18(4):1001-7. PubMed ID: 519762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution banding analysis of the involvement of strain BALB/c- and AKR-derived chromosomes No. 15 in plasmacytoma-specific translocations.
    Wiener F; Babonits M; Bregula U; Klein G; Léonard A; Wax JS; Potter M
    J Exp Med; 1984 Jan; 159(1):276-91. PubMed ID: 6607313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
    Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis.
    Potter M; Wax JS
    J Immunol; 1981 Oct; 127(4):1591-5. PubMed ID: 7276572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras.
    Silva S; Sugiyama H; Babonits M; Wiener F; Klein G
    Int J Cancer; 1991 Sep; 49(2):224-8. PubMed ID: 1879968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens.
    Potter M; Wax JS
    J Natl Cancer Inst; 1983 Aug; 71(2):391-5. PubMed ID: 6576197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas chromatographic-mass spectrometric investigation of four commercial pristane (2.6.10.14-tetramethylpentadecane) preparations used for plasmacytoma induction in BALB/c mice.
    Janz S; Birkenfeld T; Herzschuh R; Storch H
    Arch Geschwulstforsch; 1989; 59(6):415-22. PubMed ID: 2596957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous development of plasmacytomas in a selected subline of BALB/cJ mice.
    Silva S; Wang Y; Babonits M; Imreh S; Wiener F; Klein G
    Eur J Cancer; 1997 Mar; 33(3):479-85. PubMed ID: 9155535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic studies on IgA/lambda-producing murine plasmacytomas: regular occurrence of a T(12;15) translocation.
    Wiener F; Babonits M; Spira J; Klein G; Potter M
    Somatic Cell Genet; 1980 Nov; 6(6):731-8. PubMed ID: 7444720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmacytomas of the NZB mouse.
    Morse HC; Riblet R; Asofsky R; Weigert M
    J Immunol; 1978 Nov; 121(5):1969-72. PubMed ID: 712074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane.
    Byrd LG; McDonald AH; Gold LG; Potter M
    J Immunol; 1991 Nov; 147(10):3632-7. PubMed ID: 1682379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.
    Suematsu S; Matsusaka T; Matsuda T; Ohno S; Miyazaki J; Yamamura K; Hirano T; Kishimoto T
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):232-5. PubMed ID: 1729694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
    Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M
    Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice.
    McDonald AH; Degrassi A
    Cell Immunol; 1993 Jan; 146(1):157-70. PubMed ID: 8425224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
    Potter M; Morrison S; Wiener F; Zhang XK; Miller FW
    J Natl Cancer Inst; 1994 Jul; 86(14):1058-65. PubMed ID: 8021954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.